Sign Up to like & get
recommendations!
0
Published in 2024 at "Advanced Science"
DOI: 10.1002/advs.202306860
Abstract: Breast tumor‐initiating cells (BTICs) of triple‐negative breast cancer (TNBC) tissues actively repair DNA and are resistant to treatments including chemotherapy, radiotherapy, and targeted therapy. Herein, it is found that a previously reported secreted protein, sclerostin…
read more here.
Keywords:
maintenance;
tnbc;
tumor;
btic maintenance ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Nucleic Acids Research"
DOI: 10.1093/nar/gkx377
Abstract: Abstract The coordinated temporal and spatial activation of gene expression is essential for proper stem cell differentiation. The Chromodomain Helicase DNA-binding protein 1 (CHD1) is a chromatin remodeler closely associated with transcription and nucleosome turnover…
read more here.
Keywords:
chd1;
fate determination;
differentiation;
cell fate ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Nucleic Acids Research"
DOI: 10.1093/nar/gkx636
Abstract: Chd1 (Chromodomain Helicase DNA Binding Protein 1) is a conserved ATP-dependent chromatin remodeler that maintains the nucleosomal structure of chromatin, but the determinants of its specificity and its impact on gene expression are not well…
read more here.
Keywords:
chd1;
chromatin;
atp dependent;
chromatin remodeler ... See more keywords
Photo from academic.microsoft.com
Sign Up to like & get
recommendations!
1
Published in 2018 at "Nucleic Acids Research"
DOI: 10.1093/nar/gky128
Abstract: Abstract CHD1 is a conserved chromatin remodeling enzyme required for development and linked to prostate cancer in adults, yet its role in human cells is poorly understood. Here, we show that targeted disruption of the…
read more here.
Keywords:
dna damage;
chd1;
early dna;
required early ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Cancer research"
DOI: 10.1158/0008-5472.can-22-0631
Abstract: Clinical studies have shown that subsets of cancer patients achieve a significant benefit from Aurora kinase inhibitors, suggesting an urgent need to identify biomarkers for predicting drug response. Chromodomain-helicase-DNA-binding protein 1 (CHD1) is involved in…
read more here.
Keywords:
aurora kinase;
sensitivity;
aurka;
chd1 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Cancer Research"
DOI: 10.1158/1538-7445.am2018-1917
Abstract: Introduction: Therapy of metastasized prostate cancer (PCA) largely depends on androgen deprivation therapy (ADT). Despite initial response, tumors inevitably reach castration resistance (CRPC), a stage at which chemotherapy and second-generation antiandrogens (e.g. Enzalutamide) represent the…
read more here.
Keywords:
chd1;
chd1 depletion;
prostate cancer;
cancer ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Cancer Research"
DOI: 10.1158/1538-7445.genfunc25-b022
Abstract: Chromatin remodeling proteins contribute to DNA replication, transcription, repair, and recombination. The chromodomain helicase DNA-binding (CHD) family of remodelers plays crucial roles in embryonic development, neurogenesis, and carcinogenesis. As the founding member, CHD1 is capable…
read more here.
Keywords:
cancer;
prostate cancer;
tumor;
medicine ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.prca2023-a060
Abstract: Background: Epigenetic alterations can impact gene expression and have been implicated in tumorigenesis. One major process is the post-translational modification (PTM) of histone proteins governed by histone-modifying enzyme (HME) activity. There is growing evidence that…
read more here.
Keywords:
prostate cancer;
histone;
genetic alterations;
chd1 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Molecular Cancer Research"
DOI: 10.1158/1541-7786.mcr-20-0913
Abstract: Prostate cancer genomic subtypes that stratify aggressive disease and inform treatment decisions at the primary stage are currently limited. Previously, we functionally validated an aggressive subtype present in 15% of prostate cancer characterized by dual…
read more here.
Keywords:
map3k7;
loss;
cancer;
chd1 ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
2
Published in 2021 at "Therapeutic Advances in Urology"
DOI: 10.1177/17562872211022462
Abstract: Background: Prostate cancer (PCa) phenotypes vary from indolent to aggressive. Molecular subtyping may be useful in predicting aggressive cancers and directing therapy. One such subtype involving deletions of chromodomain helicase DNA binding protein 1 (CHD1),…
read more here.
Keywords:
prostate;
helicase dna;
chd1;
prostate cancer ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "PLoS Genetics"
DOI: 10.1371/journal.pgen.1009807
Abstract: Repair of DNA double-strand breaks (DSBs) by homologous recombination (HR) requires that the 5’-terminated DNA strands are resected to generate single-stranded DNA overhangs. This process is initiated by a short-range resection catalyzed by the MRX…
read more here.
Keywords:
chd1;
mrx exo1;
dna double;
double strand ... See more keywords